Takeda, Dana-Farber scientists team up on RNA startup

A former head at Takeda’s Center for External Innovation and a researcher at the Dana-Farber Cancer Institute have joined forces to launch NextRNA Therapeutics, a startup that aims to harness the potential of non-coding RNAs to make cancer and immunology drugs. Read More

Read More

Gannett’s headcount plunged 24% last year

The number of total employees at the nation’s largest newspaper owner is now down by nearly half from the most recent reported headcount just before the 2019 merger which created the company. Read More

Read More